Skye Bioscience (SKYE)
NASDAQ:SKYE
US Market
Holding SKYE?
Track your performance easily

Skye Bioscience (SKYE) Balance Sheet

190 Followers

Skye Bioscience Balance Sheet

Skye Bioscience's total assets for Q2 2024 were $87.26M, a decrease of -7.99% from the previous quarter. SKYE total liabilities were $14.45M for the fiscal quarter, a -9.40% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 11.94M$ 9.02M$ 9.86M$ 2.67M$ 2.00M
Total Liabilities
$ 14.07M$ 12.12M$ 3.99M$ 2.22M$ 1.45M
Total Equity Gross Minority
$ -2.13M$ -3.01M$ 5.86M$ 450.79K$ 548.06K
Total Capitalization
$ -1.96M$ -3.01M$ 6.35M$ 1.88M$ 935.13K
Preferred Stock Equity
-----
Capital Lease Obligations
---$ 0.00-
Currency in USD

Skye Bioscience Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis